Results 71 to 80 of about 2,219,170 (264)

Primary renal carcinoid tumor

Saudi Journal of Kidney Diseases and Transplantation, 2013
Primary renal carcinoid tumor is extremely rare and, therefore, its pathogenesis and prognosis is not well known. We report a primary renal carcinoid in a 26-year-old man treated by radical nephrectomy.
K V Kanodia, A V Vanikar, R D Patel, K S Suthar, V B Kute, P R Modi, H L Trivedi   +6 more
doaj   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Renal Tumor Biopsy Technique

Chinese Medical Journal, 2016
Objective: To review hot issues and future direction of renal tumor biopsy (RTB) technique. Data Sources: The literature concerning or including RTB technique in English was collected from PubMed published from 1990 to 2015.
Lei Zhang, Xue-Song Li, Li-Qun Zhou
doaj   +1 more source

NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD+ biosynthesis

Molecular Oncology, EarlyView.
Loss of NAPRT promotes lung tumor initiation and growth through a noncanonical mechanism, independent of its role in NAD+ biosynthesis. Mechanistically, NAPRT depletion activates the mTORC2‐driven AKT/β‐catenin signaling axis to enhance clonogenic and invasive phenotypes. Furthermore, lung‐specific Naprt deletion significantly increases tumor burden in
Myung Joon Oh, Ji Yun Jang, Yoon Jeon, Gi‐Cheon Kim, Hwanho Lee, Jooyoung Lee, Ju‐Hwa Kim, Hakhyun Kim, Minjee Kim, Ho‐Keun Kwon, Ho Lee, Hyun Seok Kim   +11 more
wiley   +1 more source

Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization [PDF]

, 1994
We analyzed 19 chromophobe renal cell carcinomas by means of comparative genomic hybridization. Two tumors revealed no numerical abnormalities. In the remaining 17 cases we found loss of entire chromosomes with underrepresentation of chromosome 1 ...
Speicher, Michael R., Cremer, Thomas, Kovacs, Gyula, Störkel, S., Ried, Thomas, Schoell, B., Manoir, Stanislas du, Schröck, Evelin   +7 more
core   +1 more source

Renal carcinoid tumor

Saudi Journal of Kidney Diseases and Transplantation, 2009
Primary renal carcinoid is a rare tumor, until now less than 50 cases of this tumor has been reported, so very little is known about its presentation clinicopathologic patterns and prognosis.
Geramizadeh Bita, Khezri Abdolaziz, Shariat Mahmoud   +2 more
doaj  

Do Renal Tumor Characteristics Affect the Number of Hemostatic Agents Used During Partial Nephrectomy?

, 2019
Objective:The aim of this study was to investigate the use and types of hemostatic agents (HAs) used during partial nephrectomy (PN) and the relationship of the number of these agents used during surgery with tumor size, RENAL nephrometry score (NS ...
Hilal Şahin, Yusuf Özlem İlbey, Mehmet Yiğit Yalçın, Erdem Kısa, Cem Yücel, Mehmet Zeynel Keskin, Özgür Çakmak   +6 more
core   +1 more source

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

FEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar, Sally Agersborg, Ahmed Charifa, Pooja Phull, Noa Biran, David Vesole, Harsh Parmar, Andrew Pecora, Andrew Ip, Andre Goy, David Siegel, Maher Albitar   +11 more
wiley   +1 more source

Five‐Year Outcomes of Laparoscopic Sphincter‐Preserving Surgery for Rectal Cancer: A Prospective Study in Elderly Vietnamese Patients

Aging and Cancer, EarlyView.
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho, Quang Le, Ngoc Thach Tran, Van Viet Ung, Loc Vu   +4 more
wiley   +1 more source

Handling and staging of renal cell carcinoma the international society of urological pathology consensus (ISUP) conference recommendations

, 2013
The International Society of Urologic Pathology 2012 Consensus Conference on renal cancer, through working group 3, focused on the issues of staging and specimen handling of renal tumors.
Martignoni G., Evans A., Montironi, Rodolfo, Bonsib, S.M., Rezaei K., Bonsib, Stephen M., Fajardo D., Cathro H., Lloreta J., Amin, Mahul B, Gupta N., Kida M., Grignon D. J., Shanks J., Srinivasan B., Griffiths D., Latour M., Montironi, R., Humphrey P., Abraham A., Nichols P., Osunkoya A., Delahunt, B, Murphy H., Grignon D.J., Pyda-Karwicka M., Van Der Kwast T., Fine S., Kristiansen G., Warren A., Delahunt B., Falzarano S., Tamboli P., Srigley, John R., Billis, A., Bostwick D., Ronchetti R., Iczkowski K., Trias I., Allan R., ,, Kench J., Nazeer T., Billis, Athanase, Hulsbergen-van de Kaa, C.A., Deng F.-M., Chen Y.-B., Samaratunga, H, Lopez-Beltran, A., the ISUP Renal Tumor Panel, Trpkov, K., Zhao J., Hirsch M., Amin, Mahul B., Tan P.H., Amin M. B., Bethwaite P., Egevad, Lars, Reuter V., Egevad, L., Lopez-Beltran, Antonio, Egevad, L,, Srigley J.R., Jones E., Lewin C., Sweet J., Argani P., Suzigan S., Ghayouri M., Lie K., Russell L., Nesi G., Vakar-Lopez F., Tickoo S., Srigley J. R., McHale T., Shen S., Tamboli, Pheroze, Cheville J., Wang C., Grignon, David J, Rioux-Leclercq N., Lopez Beltran A., Tamboli, P., Giannico G., Ahmed K., Shabaik A., Jufe L.I., Billis, A, Bonsib, Stephen M, Samaratunga H., Amin, MB, Huang W., Brimo F., Axcrona U., Petraki C., Tamboli, P, Gokden N., Samaratunga, H., Hes O., Shevchuk M., Hussein S., Maclean F., the members of the ISUP Renal Tumor Panel, Miller R., Billis A., Zynger D., Yilmaz A., Parwani A., Birbe R., Loftus B., Lopez-Beltran, A, Bonsib S.M., Perry-Keene J., Amin, M.B., Miyamoto H., Al Ahmadie H., Crist H., Hameed O., Cheng L., Ganji M., Robinson B., True L., Pan C.-C., Picken M., Adeniran A., Berney D., Egevad L., Nacey J., Epstein J., Montironi R., Ozagari A., Samaratunga, Hemamali, Moch H., Bonsib S. M., Fridman E., Lane Z., Furusato B., Rohan S., Bonsib, SM, Barry M., Baydar D., Tsuzuki T., Delahunt, B., Cohen C., Kunju L.P., et al., Cho Y.M., Magi-Galluzzi C., Shah R., Delprado W., Fadare O., Huang J., Grignon, David J., Olgac S., Trpkov, K, Jimenez R., Sibony M., Srigley, John R, Merino M., Chuang A.-Y., Netto G., Zhou M., McKenney J., Takahashi H., Srigley, J.R., Van De Kaa C.H., Orozco R., Trpkov, Kiril, Scarpelli M., Yao J., Delahunt, Brett, Amin M.B., Grignon, DJ, Begin L., Algaba F., Fleming S., O'Donnell M., Susani M., Grignon, D.J., Lopez-Beltran A., Trpkov K.   +181 more
core   +1 more source